[Nitric oxide donors in therapy of chronic heart failure].
Blasini
R
R
Medizinische Klinik, Klinikum rechts, Isar und Deutsches Herzzentrum München, Technische Universität München.
Lehmann
G
G
Schömig
A
A
D002908:Chronic Disease; D004361:Drug Tolerance; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008981:Molsidomine / Q000009:adverse effects / Q000627:therapeutic use*; D009566:Nitrates / Q000009:adverse effects / Q000627:therapeutic use*; D009569:Nitric Oxide / Q000502:physiology / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*
D009566:Nitrates; D014665:Vasodilator Agents; D009569:Nitric Oxide; D008981:Molsidomine